ArticlePLOS global public health2024

Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study.

Nigel Garrett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.